Schneider Electric Infrastructure Limited (NSE:SCHNEIDER)

SpringWorks Therapeutics Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	26,367	22,067	17,772	15,303	12,971
Revenue Growth (YoY)	19.49%	24.17%	16.13%	17.98%	-6.30%
Cost of Revenue	16,305	14,157	12,223	10,956	9,094
Gross Profit	10,062	7,910	5,549	4,347	3,878
Selling, General & Admin	3,015	2,788	2,431	2,215	1,957
Other Operating Expenses	3,220	2,146	1,400	1,240	1,251
Operating Expenses	6,488	5,154	4,017	3,628	3,430
Operating Income	3,574	2,756	1,532	719.76	447.95
Interest Expense	-492.8	-660.4	-505	-460.01	-464.8
Interest & Investment Income	-	6.2	-	0.9	2.1
Currency Exchange Gain (Loss)	-	-18.8	-38.3	-31.52	-31.23
Other Non Operating Income (Expenses)	245.7	57.1	96.6	49.07	129.95
EBT Excluding Unusual Items	3,327	2,140	1,085	278.2	83.97
Merger & Restructuring Charges	-	-41.2	-3.8	-26	-130.12
Gain (Loss) on Sale of Assets	-	1.2	-1.5	-0.15	2.3
Other Unusual Items	176.5	-	156.8	24.17	33.74
Pretax Income	3,504	2,100	1,236	276.22	-10.11
Income Tax Expense	824.6	379.6	-	-	-
Net Income	2,679	1,720	1,236	276.22	-10.11
Net Income to Common	2,679	1,720	1,236	276.22	-10.11
Net Income Growth	55.72%	39.15%	347.58%	-	-
Shares Outstanding (Basic)	239	239	239	239	239
Shares Outstanding (Diluted)	239	239	239	239	239
Shares Change (YoY)	0.03%	-	-	-	0.00%
EPS (Basic)	11.20	7.19	5.17	1.16	-0.04
EPS (Diluted)	11.20	7.19	5.17	1.16	-0.04
EPS Growth	55.77%	39.07%	347.53%	-	-
Free Cash Flow	2,448	1,340	499.3	948.3	-26.9
Free Cash Flow Per Share	10.23	5.60	2.09	3.97	-0.11
Gross Margin	38.16%	35.85%	31.22%	28.41%	29.89%
Operating Margin	13.55%	12.49%	8.62%	4.70%	3.45%
Profit Margin	10.16%	7.80%	6.96%	1.80%	-0.08%
Free Cash Flow Margin	9.28%	6.07%	2.81%	6.20%	-0.21%
EBITDA	3,828	2,937	1,684	859.99	613.98
EBITDA Margin	14.52%	13.31%	9.48%	5.62%	4.73%
D&A For EBITDA	253.6	180.7	152.5	140.23	166.03
EBIT	3,574	2,756	1,532	719.76	447.95
EBIT Margin	13.55%	12.49%	8.62%	4.70%	3.45%
Effective Tax Rate	23.54%	18.08%	-	-	-
Revenue as Reported	26,613	22,160	17,894	15,402	13,157

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.